SHMT2 and gastric cancer: Moreover, we also analysed the expression of P53, Ki-67, VEGFR, CD133, and E-cadherin in GC, and the results showed that there was a statistically significant difference in the expression of SHMT2, P53, VEGFR, and CD133.